We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » UK Regulators, Industry Spar Over Drug Development Costs
UK Regulators, Industry Spar Over Drug Development Costs
September 11, 2013
British regulators are questioning whether the cost of drug development is unnecessarily high, in response to editorials in The Times of London warning of a potential manufacturing exodus.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor